33.86 USD
-0.5 (-1.46%)
At close: Feb 9, 2026
33.86 USD
0 (0%)
After Hours: 2/9/2026, 8:08:24 PM
We assign a fundamental rating of 5 out of 10 to INDV. INDV was compared to 191 industry peers in the Pharmaceuticals industry. While INDV has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on INDV.
1. Profitability
1.1 Basic Checks
- In the past year INDV was profitable.
- In the past year INDV had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: INDV reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 8.62%, INDV belongs to the top of the industry, outperforming 90.05% of the companies in the same industry.
- The Return On Invested Capital of INDV (50.62%) is better than 100.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for INDV is significantly above the industry average of 12.63%.
- The last Return On Invested Capital (50.62%) for INDV is above the 3 year average (43.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROIC | 50.62% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
- With an excellent Profit Margin value of 10.34%, INDV belongs to the best of the industry, outperforming 83.77% of the companies in the same industry.
- In the last couple of years the Profit Margin of INDV has declined.
- INDV's Operating Margin of 24.49% is amongst the best of the industry. INDV outperforms 91.62% of its industry peers.
- In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
- With an excellent Gross Margin value of 85.51%, INDV belongs to the best of the industry, outperforming 88.48% of the companies in the same industry.
- INDV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INDV is creating value.
- The number of shares outstanding for INDV has been reduced compared to 1 year ago.
- INDV has less shares outstanding than it did 5 years ago.
- INDV has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.69 indicates that INDV is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.69, INDV is in the better half of the industry, outperforming 65.97% of the companies in the same industry.
- The Debt to FCF ratio of INDV is 2.68, which is a good value as it means it would take INDV, 2.68 years of fcf income to pay off all of its debts.
- INDV's Debt to FCF ratio of 2.68 is amongst the best of the industry. INDV outperforms 92.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Altman-Z | 2.69 |
ROIC/WACC5.23
WACC9.68%
2.3 Liquidity
- INDV has a Current Ratio of 0.96. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Current ratio of INDV (0.96) is worse than 86.39% of its industry peers.
- A Quick Ratio of 0.79 indicates that INDV may have some problems paying its short term obligations.
- INDV has a worse Quick ratio (0.79) than 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 256.36% over the past year.
- The earnings per share for INDV have been decreasing by -53.19% on average. This is quite bad
- INDV shows a decrease in Revenue. In the last year, the revenue decreased by -0.25%.
- The Revenue has been growing by 8.64% on average over the past years. This is quite good.
EPS 1Y (TTM)256.36%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%33.33%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
3.2 Future
- The Earnings Per Share is expected to grow by 37.61% on average over the next years. This is a very strong growth
- INDV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.36% yearly.
EPS Next Y440.8%
EPS Next 2Y161.63%
EPS Next 3Y95.81%
EPS Next 5Y37.61%
Revenue Next Year3.67%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.6%
Revenue Next 5Y1.36%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 17.28, INDV is valued on the expensive side.
- Compared to the rest of the industry, the Price/Earnings ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 85.34% of the companies listed in the same industry.
- INDV is valuated rather cheaply when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 11.24, the valuation of INDV can be described as reasonable.
- Based on the Price/Forward Earnings ratio, INDV is valued cheaper than 87.43% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 27.86. INDV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.28 | ||
| Fwd PE | 11.24 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 84.29% of the companies listed in the same industry.
- INDV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INDV is cheaper than 80.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.23 | ||
| EV/EBITDA | 13.03 |
4.3 Compensation for Growth
- INDV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of INDV may justify a higher PE ratio.
- A more expensive valuation may be justified as INDV's earnings are expected to grow with 95.81% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y161.63%
EPS Next 3Y95.81%
5. Dividend
5.1 Amount
- No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
33.86
-0.5 (-1.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-26 2026-02-26/amc
Inst Owners92.33%
Inst Owner Change0.83%
Ins Owners3.78%
Ins Owner Change5.64%
Market Cap4.23B
Revenue(TTM)1.18B
Net Income(TTM)122.00M
Analysts84.62
Price Target46.48 (37.27%)
Short Float %9.74%
Short Ratio4.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.89%
Min EPS beat(2)71.47%
Max EPS beat(2)92.31%
EPS beat(4)4
Avg EPS beat(4)70.49%
Min EPS beat(4)45.92%
Max EPS beat(4)92.31%
EPS beat(8)6
Avg EPS beat(8)12.14%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.31%
Min Revenue beat(2)17.53%
Max Revenue beat(2)21.1%
Revenue beat(4)4
Avg Revenue beat(4)14.97%
Min Revenue beat(4)8.6%
Max Revenue beat(4)21.1%
Revenue beat(8)5
Avg Revenue beat(8)7.48%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20.38%
PT rev (3m)212.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.43%
EPS NY rev (3m)81.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1%
Revenue NY rev (3m)13.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.28 | ||
| Fwd PE | 11.24 | ||
| P/S | 3.58 | ||
| P/FCF | 35.23 | ||
| P/OCF | 23.49 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.03 |
EPS(TTM)1.96
EY5.79%
EPS(NY)3.01
Fwd EY8.9%
FCF(TTM)0.96
FCFY2.84%
OCF(TTM)1.44
OCFY4.26%
SpS9.45
BVpS-1.66
TBVpS-1.67
PEG (NY)0.04
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROCE | 64.08% | ||
| ROIC | 50.62% | ||
| ROICexc | 3805.17% | ||
| ROICexgc | 5707.75% | ||
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% | ||
| FCFM | 10.17% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Debt/EBITDA | 0.97 | ||
| Cap/Depr | 230.77% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.14% | ||
| Profit Quality | 98.36% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.69 |
F-Score8
WACC9.68%
ROIC/WACC5.23
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)256.36%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%33.33%
EPS Next Y440.8%
EPS Next 2Y161.63%
EPS Next 3Y95.81%
EPS Next 5Y37.61%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
Revenue Next Year3.67%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.6%
Revenue Next 5Y1.36%
EBIT growth 1Y8.24%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year1050.98%
EBIT Next 3Y148.27%
EBIT Next 5Y64.69%
FCF growth 1Y236.36%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y446.15%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%
INDIVIOR PHARMACEUTICALS INC / INDV FAQ
What is the fundamental rating for INDV stock?
ChartMill assigns a fundamental rating of 5 / 10 to INDV.
What is the valuation status of INDIVIOR PHARMACEUTICALS INC (INDV) stock?
ChartMill assigns a valuation rating of 8 / 10 to INDIVIOR PHARMACEUTICALS INC (INDV). This can be considered as Undervalued.
What is the profitability of INDV stock?
INDIVIOR PHARMACEUTICALS INC (INDV) has a profitability rating of 7 / 10.
How financially healthy is INDIVIOR PHARMACEUTICALS INC?
The financial health rating of INDIVIOR PHARMACEUTICALS INC (INDV) is 4 / 10.
Is the dividend of INDIVIOR PHARMACEUTICALS INC sustainable?
The dividend rating of INDIVIOR PHARMACEUTICALS INC (INDV) is 0 / 10 and the dividend payout ratio is 0%.